Justin Moore

Justin Moore serves as a secondary procurement liaison within the Office of the Assistant Secretary for Preparedness and Response at the Department of Health and Human Services, supporting the strategic acquisition of medical countermeasures to address public health emergencies. While not the primary contracting officer, he plays a critical role in facilitating the end-to-end procurement lifecycle for biodefense-related contracts, including pre-solicitation planning, vendor engagement, and contract administration. His work directly supports the agency’s mission to accelerate the development and deployment of vaccines, therapeutics, and diagnostics against biological threats, ensuring timely access to critical medical capabilities through expedited acquisition pathways. Moore maintains consistent procurement relationships with specialized biopharmaceutical contractors, including Cidara Therapeutics, Aquestive Therapeutics, Rafah Laboratories, and Osivax, all of which possess advanced capabilities in antiviral formulations, drug delivery systems, and novel vaccine platforms. His contracting patterns reflect a preference for partners with established expertise in GMP-compliant biological product manufacturing, often engaging firms with prior BARDA collaboration history. These relationships are characterized by long-term, mission-aligned partnerships focused on rapid response readiness and scalable production capacity. Moore’s procurement activity shows no use of socioeconomic set-asides, with 100% of awards issued under full and open competition. This reflects the agency’s prioritization of technical capability and speed over socioeconomic criteria in high-stakes public health emergencies, where proven manufacturing scale and regulatory compliance are paramount. While small business participation is not formally incentivized in his portfolio, vendors of all sizes must meet stringent technical and quality benchmarks. His procurement focus is exclusively centered on NAICS 325414—Biological Product (except Diagnostic) Manufacturing—encompassing vaccines, monoclonal antibodies, antivirals, and other biologic therapeutics. He specializes in procuring complex, high-containment products requiring FDA licensure and CDC alignment, demonstrating deep domain expertise in biodefense manufacturing and regulatory pathways.